Notal Vision Inc. (U.S. Headquarters)

7717 Coppermine Dr.
Manassas, VA 20109
Patient-inquiries: 1-888-910-2020; M-F 8AM to 8PM EST
Physician-inquiries: 1-855-600-3112; M-F 9AM to 4PM EST

Notal Vision Ltd. Headquarters:

5 Droyanov St.
Tel Aviv, Israel

FDA Indication for Use

The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

The ForeseeHome AMD Monitoring Program is only available by physician order and is intended to be used as an addition to regular eye exams.

The ForeseeHome AMD Monitoring Program is covered by Medicare, subject to its coverage requirements for the test, to assess patients with dry AMD who are at risk of developing wet AMD.